Jiandong Zhang

Dr. Jiandong Zhang

orcid

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 January 2018 in Journal of the American Society of Nephrology
Verified
Journal Article
Closed access
PDF file
LLLin-Li Lv
Lin-Li Lv
YFYe Feng
Ye Feng
YWYi Wen
Yi Wen
WWWei-Jun Wu
Wei-Jun Wu
HNHai-Feng Ni
Hai-Feng Ni
BLBi-Cheng Liu
Bi-Cheng Liu
Albuminuria is a key instigator of tubulointerstitial inflammation associated with CKD, but the mechanism through which filtered albumin propagates renal injury remains unclear. In this study, we explored the role in this process of exosome mRNA released from tubular epithelial cells (TECs). Compared with control mice, acute and chronic kidney injury models had more exosomes containing inflammatory cytokine mRNA, particularly the chemokine CCL2, in kidneys and urine. In vitro stimulation of TECs with BSA recapitulated this finding. Notably, the internalization of purified TEC exosomes by cultured macrophages increased if TECs were exposed to BSA. Macrophage internalization of exosomes from BSA-treated TECs led to an enhanced inflammatory response and macrophage migration, but CCL2 silencing in TECs prevented these effects. Using a GFP-CCL2 fusion mRNA construct, we observed direct transfer of CCL2 mRNA from TEC exosomes to macrophages. Mice subjected to tail vein injection of purified BSA-treated TEC exosomes developed tubular injury with renal inflammatory cell infiltration. However, injection of exosomes from BSA-treated CCL2-deficient TECs induced less severe kidney inflammation. Finally, in patients with IgA nephropathy, the increase of proteinuria correlated with augmented urinary excretion of exosomes with exaggerated expression of CCL2 mRNA. Moreover, the level of CCL2 mRNA in urinary exosomes correlated closely with levels of renal interstitial macrophage infiltration in these patients. Our studies demonstrate that the increasing release of exosomes that transfer CCL2 mRNA from TECs to macrophages constitutes a critical mechanism of albumin-induced tubulointerstitial inflammation.

23 July 2019 in Journal of the American Society of Nephrology
Verified
Journal Article
Closed access
PDF file
YWYi Wen
Yi Wen
XLXiaohan Lu
Xiaohan Lu
JRJiafa Ren
Jiafa Ren
JPJamie R. Privratsky
Jamie R. Privratsky
BYBo Yang
Bo Yang
SCSteven D. Crowley
Steven D. Crowley
Significance Statement: Proinflammatory M1 macrophages initiate kidney injury, but mechanisms through which persistent M1-dependent kidney damage culminates in fibrosis of the kidney require elucidation. In murine CKD models featuring robust macrophage accumulation, the authors found that macrophage-specific deficiency of Krüppel-like factor 4 (KLF4, a zinc-finger transcription factor that suppresses inflammation) augmented the M1 polarization and expression of TNFα (KLF4’s downstream effector) in macrophages infiltrating the kidney, as well as exacerbated glomerular matrix deposition, tubular damage, and interstitial fibrosis. Mice with macrophage-specific TNF deletion exhibited decreased kidney damage and fibrosis. TNF receptor-1 inhibition in wild-type mice and mice with macrophage-specific KLF4 deficiency reduced susceptibility to kidney damage, fibrosis, and necroptosis, and abrogated differences in these parameters between experimental groups. These findings indicate that macrophage KLF4 ameliorates CKD by mitigating TNF-dependent injury and fibrosis. Background: Polarized macrophage populations can orchestrate both inflammation of the kidney and tissue repair during CKD. Proinflammatory M1 macrophages initiate kidney injury, but mechanisms through which persistent M1-dependent kidney damage culminates in fibrosis require elucidation. Krüppel-like factor 4 (KLF4), a zinc-finger transcription factor that suppresses inflammatory signals, is an essential regulator of macrophage polarization in adipose tissues, but the effect of myeloid KLF4 on CKD progression is unknown. Methods: We used conditional mutant mice lacking KLF4 or TNFα (KLF4’s downstream effector) selectively in myeloid cells to investigate macrophage KLF4’s role in modulating CKD progression in two models of CKD that feature robust macrophage accumulation, nephrotoxic serum nephritis, and unilateral ureteral obstruction. Results: In these murine CKD models, KLF4 deficiency in macrophages infiltrating the kidney augmented their M1 polarization and exacerbated glomerular matrix deposition and tubular epithelial damage. During the induced injury in these models, macrophage-specific KLF4 deletion also exacerbated kidney fibrosis, with increased levels of collagen 1 and α-smooth muscle actin in the injured kidney. CD11b+Ly6Chi myeloid cells isolated from injured kidneys expressed higher levels of TNFα mRNA versus wild-type controls. In turn, mice bearing macrophage-specific deletion of TNFα exhibited decreased glomerular and tubular damage and attenuated kidney fibrosis in the models. Moreover, treatment with the TNF receptor-1 inhibitor R-7050 during nephrotoxic serum nephritis reduced damage, fibrosis, and necroptosis in wild-type mice and mice with KLF4-deficient macrophages, and abrogated the differences between the two groups in these parameters. Conclusions: These data indicate that macrophage KLF4 ameliorates CKD by mitigating TNF-dependent injury and fibrosis.

1 December 2014 in Hypertension
Verified
Journal Article
Closed access
PDF file
JZJiandong Zhang
Jiandong Zhang
MPMehul B. Patel
Mehul B. Patel
RGRobert Griffiths
Robert Griffiths
AMAlice Mao
Alice Mao
YSYoung-Soo Song
Young-Soo Song
SCSteven D. Crowley
Steven D. Crowley
Immune system activation contributes to the pathogenesis of hypertension and the resulting progression of chronic kidney disease. In this regard, we recently identified a role for proinflammatory Th1 T-lymphocyte responses in hypertensive kidney injury. Because Th1 cells generate interferon-γ and tumor necrosis factor-α (TNF-α), we hypothesized that interferon-γ and TNF-α propagate renal damage during hypertension induced by activation of the renin–angiotensin system. Therefore, after confirming that mice genetically deficient of Th1 immunity were protected from kidney glomerular injury despite a preserved hypertensive response, we subjected mice lacking interferon-γ or TNF-α to our model of hypertensive chronic kidney disease. Interferon deficiency had no impact on blood pressure elevation or urinary albumin excretion during chronic angiotensin II infusion. By contrast, TNF-deficient (knockout) mice had blunted hypertensive responses and reduced end-organ damage in our model. As angiotensin II–infused TNF knockout mice had exaggerated endothelial nitric oxide synthase expression in the kidney and enhanced nitric oxide bioavailability, we examined the actions of TNF-α generated from renal parenchymal cells in hypertension by transplanting wild-type or TNF knockout kidneys into wild-type recipients before the induction of hypertension. Transplant recipients lacking TNF solely in the kidney had blunted hypertensive responses to angiotensin II and augmented renal endothelial nitric oxide synthase expression, confirming a role for kidney-derived TNF-α to promote angiotensin II–induced blood pressure elevation by limiting renal nitric oxide generation.

1 February 2016 in Cell Metabolism
Verified
Journal Article
Closed access
JZJiandong Zhang
Jiandong Zhang
NRNathan P. Rudemiller
Nathan P. Rudemiller
MPMehul B. Patel
Mehul B. Patel
NKNorah S. Karlovich
Norah S. Karlovich
MWMin Wu
Min Wu
SCSteven D. Crowley
Steven D. Crowley

8 June 2012 in Circulation Research
Verified
Journal Article
Closed access
PDF file
JZJiandong Zhang
Jiandong Zhang
MPMehul B. Patel
Mehul B. Patel
YSYoung-Soo Song
Young-Soo Song
RGRobert Griffiths
Robert Griffiths
JBJames Burchette
James Burchette
SCSteven D. Crowley
Steven D. Crowley
Rationale:: Human clinical trials using type 1 angiotensin (AT 1 ) receptor antagonists indicate that angiotensin II is a critical mediator of cardiovascular and renal disease. However, recent studies have suggested that individual tissue pools of AT 1 receptors may have divergent effects on target organ damage in hypertension. Objective:: We examined the role of AT 1 receptors on T lymphocytes in the pathogenesis of hypertension and its complications. Methods and Results:: Deficiency of AT 1 receptors on T cells potentiated kidney injury during hypertension with exaggerated renal expression of chemokines and enhanced accumulation of T cells in the kidney. Kidneys and purified CD4 + T cells from “T cell knockout” mice lacking AT 1 receptors on T lymphocytes had augmented expression of Th1-associated cytokines including interferon-γ and tumor necrosis factor-α. Within T lymphocytes, the transcription factors T-bet and GATA-3 promote differentiation toward the Th1 and Th2 lineages, respectively, and AT 1 receptor-deficient CD4 + T cells had enhanced T-bet/GATA-3 expression ratios favoring induction of the Th1 response. Inversely, mice that were unable to mount a Th1 response due to T-bet deficiency were protected from kidney injury in our hypertension model. Conclusions:: The current studies identify an unexpected role for AT 1 receptors on T lymphocytes to protect the kidney in the setting of hypertension by favorably modulating CD4 + T helper cell differentiation.

1 April 2015 in Current Opinion in Pharmacology
Verified
Journal Article
Closed access
JZJiandong Zhang
Jiandong Zhang
SCSteven D Crowley
Steven D Crowley